-
1
-
-
79960427057
-
Selective killing of cancer cells by a small molecule targeting the stress response to ROS
-
Raj L., Ide T., Gurkar A.U., Foley M., Schenone M., Li X., Tolliday N.J., Golub T.R., Carr S.A., Shamji A.F., Stern A.M., Mandinova A., Schreiber S.L., Lee S.W. Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature 2011, 475:231-234.
-
(2011)
Nature
, vol.475
, pp. 231-234
-
-
Raj, L.1
Ide, T.2
Gurkar, A.U.3
Foley, M.4
Schenone, M.5
Li, X.6
Tolliday, N.J.7
Golub, T.R.8
Carr, S.A.9
Shamji, A.F.10
Stern, A.M.11
Mandinova, A.12
Schreiber, S.L.13
Lee, S.W.14
-
2
-
-
0036083396
-
The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction
-
Glickman M.H., Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 2002, 82:373-428.
-
(2002)
Physiol. Rev.
, vol.82
, pp. 373-428
-
-
Glickman, M.H.1
Ciechanover, A.2
-
3
-
-
21344469230
-
Increased proteasome activity, ubiquitin-conjugating enzymes, and eEF1A translation factor detected in breast cancer tissue
-
Chen L., Madura K. Increased proteasome activity, ubiquitin-conjugating enzymes, and eEF1A translation factor detected in breast cancer tissue. Cancer Res. 2005, 65:5599-5606.
-
(2005)
Cancer Res.
, vol.65
, pp. 5599-5606
-
-
Chen, L.1
Madura, K.2
-
4
-
-
0036217332
-
Proteasome inhibition: a novel approach to cancer therapy
-
Adams J. Proteasome inhibition: a novel approach to cancer therapy. Trends Mol. Med. 2002, 8:S49-54.
-
(2002)
Trends Mol. Med.
, vol.8
-
-
Adams, J.1
-
5
-
-
2342613652
-
The proteasome: a suitable antineoplastic target
-
Adams J. The proteasome: a suitable antineoplastic target. Nat. Rev. Cancer 2004, 4:349-360.
-
(2004)
Nat. Rev. Cancer
, vol.4
, pp. 349-360
-
-
Adams, J.1
-
6
-
-
70249146895
-
Single-agent bortezomib in previously untreated multiple myeloma: efficacy, characterization of peripheral neuropathy, and molecular correlations with response and neuropathy
-
Richardson P.G., Xie W., Mitsiades C., Chanan-Khan A.A., Lonial S., Hassoun H., Avigan D.E., Oaklander A.L., Kuter D.J., Wen P.Y., Kesari S., Briemberg H.R., Schlossman R.L., Munshi N.C., Heffner L.T., Doss D., Esseltine D.L., Weller E., Anderson K.C., Amato A.A. Single-agent bortezomib in previously untreated multiple myeloma: efficacy, characterization of peripheral neuropathy, and molecular correlations with response and neuropathy. J. Clin. Oncol. 2009, 27:3518-3525.
-
(2009)
J. Clin. Oncol.
, vol.27
, pp. 3518-3525
-
-
Richardson, P.G.1
Xie, W.2
Mitsiades, C.3
Chanan-Khan, A.A.4
Lonial, S.5
Hassoun, H.6
Avigan, D.E.7
Oaklander, A.L.8
Kuter, D.J.9
Wen, P.Y.10
Kesari, S.11
Briemberg, H.R.12
Schlossman, R.L.13
Munshi, N.C.14
Heffner, L.T.15
Doss, D.16
Esseltine, D.L.17
Weller, E.18
Anderson, K.C.19
Amato, A.A.20
more..
-
7
-
-
33749335282
-
The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease
-
Lamb J., Crawford E.D., Peck D., Modell J.W., Blat I.C., Wrobel M.J., Lerner J., Brunet J.P., Subramanian A., Ross K.N., Reich M., Hieronymus H., Wei G., Armstrong S.A., Haggarty S.J., Clemons P.A., Wei R., Carr S.A., Lander E.S., Golub T.R. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 2006, 313:1929-1935.
-
(2006)
Science
, vol.313
, pp. 1929-1935
-
-
Lamb, J.1
Crawford, E.D.2
Peck, D.3
Modell, J.W.4
Blat, I.C.5
Wrobel, M.J.6
Lerner, J.7
Brunet, J.P.8
Subramanian, A.9
Ross, K.N.10
Reich, M.11
Hieronymus, H.12
Wei, G.13
Armstrong, S.A.14
Haggarty, S.J.15
Clemons, P.A.16
Wei, R.17
Carr, S.A.18
Lander, E.S.19
Golub, T.R.20
more..
-
8
-
-
84856085129
-
Inhibition of proteasome deubiquitinating activity as a new cancer therapy
-
D'Arcy P., Brnjic S., Olofsson M.H., Fryknas M., Lindsten K., De Cesare M., Perego P., Sadeghi B., Hassan M., Larsson R., Linder S. Inhibition of proteasome deubiquitinating activity as a new cancer therapy. Nat. Med. 2011, 17:1636-1640.
-
(2011)
Nat. Med.
, vol.17
, pp. 1636-1640
-
-
D'Arcy, P.1
Brnjic, S.2
Olofsson, M.H.3
Fryknas, M.4
Lindsten, K.5
De Cesare, M.6
Perego, P.7
Sadeghi, B.8
Hassan, M.9
Larsson, R.10
Linder, S.11
-
9
-
-
26444494585
-
Endoplasmic reticulum stress compromises the ubiquitin-proteasome system
-
Menendez-Benito V., Verhoef L.G., Masucci M.G., Dantuma N.P. Endoplasmic reticulum stress compromises the ubiquitin-proteasome system. Hum. Mol. Genet. 2005, 14:2787-2799.
-
(2005)
Hum. Mol. Genet.
, vol.14
, pp. 2787-2799
-
-
Menendez-Benito, V.1
Verhoef, L.G.2
Masucci, M.G.3
Dantuma, N.P.4
-
10
-
-
75549089718
-
Network and pathway analysis of compound-protein interactions
-
Brennan R.J., Nikolskya T., Bureeva S. Network and pathway analysis of compound-protein interactions. Methods Mol. Biol. 2009, 575:225-247.
-
(2009)
Methods Mol. Biol.
, vol.575
, pp. 225-247
-
-
Brennan, R.J.1
Nikolskya, T.2
Bureeva, S.3
-
11
-
-
50349098488
-
The fluorometric microculture cytotoxicity assay
-
Lindhagen E., Nygren P., Larsson R. The fluorometric microculture cytotoxicity assay. Nat. Protoc. 2008, 3:1364-1369.
-
(2008)
Nat. Protoc.
, vol.3
, pp. 1364-1369
-
-
Lindhagen, E.1
Nygren, P.2
Larsson, R.3
-
12
-
-
0035839603
-
Cyclopentenone prostaglandins of the J series inhibit the ubiquitin isopeptidase activity of the proteasome pathway
-
Mullally J.E., Moos P.J., Edes K., Fitzpatrick F.A. Cyclopentenone prostaglandins of the J series inhibit the ubiquitin isopeptidase activity of the proteasome pathway. J. Biol. Chem. 2001, 276:30366-30373.
-
(2001)
J. Biol. Chem.
, vol.276
, pp. 30366-30373
-
-
Mullally, J.E.1
Moos, P.J.2
Edes, K.3
Fitzpatrick, F.A.4
-
13
-
-
33646406554
-
Celastrol, a triterpene extracted from the Chinese " Thunder of God Vine" , is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice
-
Yang H., Chen D., Cui Q.C., Yuan X., Dou Q.P. Celastrol, a triterpene extracted from the Chinese " Thunder of God Vine" , is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice. Cancer Res. 2006, 66:4758-4765.
-
(2006)
Cancer Res.
, vol.66
, pp. 4758-4765
-
-
Yang, H.1
Chen, D.2
Cui, Q.C.3
Yuan, X.4
Dou, Q.P.5
-
14
-
-
33846454701
-
The tumor proteasome is a primary target for the natural anticancer compound Withaferin A isolated from " Indian winter cherry"
-
Yang H., Shi G., Dou Q.P. The tumor proteasome is a primary target for the natural anticancer compound Withaferin A isolated from " Indian winter cherry" Mol. Pharmacol. 2007, 71:426-437.
-
(2007)
Mol. Pharmacol.
, vol.71
, pp. 426-437
-
-
Yang, H.1
Shi, G.2
Dou, Q.P.3
-
15
-
-
0032539702
-
Potent and selective inhibitors of the proteasome: dipeptidyl boronic acids
-
Adams J., Behnke M., Chen S., Cruickshank A.A., Dick L.R., Grenier L., Klunder J.M., Ma Y.T., Plamondon L., Stein R.L. Potent and selective inhibitors of the proteasome: dipeptidyl boronic acids. Bioorg. Med. Chem. Lett. 1998, 8:333-338.
-
(1998)
Bioorg. Med. Chem. Lett.
, vol.8
, pp. 333-338
-
-
Adams, J.1
Behnke, M.2
Chen, S.3
Cruickshank, A.A.4
Dick, L.R.5
Grenier, L.6
Klunder, J.M.7
Ma, Y.T.8
Plamondon, L.9
Stein, R.L.10
-
16
-
-
79955470830
-
Trimming of ubiquitin chains by proteasome-associated deubiquitinating enzymes
-
R110 003871
-
Lee M.J., Lee B.H., Hanna J., King R.W., Finley D. Trimming of ubiquitin chains by proteasome-associated deubiquitinating enzymes. Mol. Cell Proteomics 2011, 10. R110 003871.
-
(2011)
Mol. Cell Proteomics
, vol.10
-
-
Lee, M.J.1
Lee, B.H.2
Hanna, J.3
King, R.W.4
Finley, D.5
-
17
-
-
84866559458
-
Synthesis, cellular evaluation, and mechanism of action of piperlongumine analogs
-
Adams D.J., Dai M., Pellegrino G., Wagner B.K., Stern A.M., Shamji A.F., Schreiber S.L. Synthesis, cellular evaluation, and mechanism of action of piperlongumine analogs. Proc. Natl. Acad. Sci. USA 2012, 109:15115-15120.
-
(2012)
Proc. Natl. Acad. Sci. USA
, vol.109
, pp. 15115-15120
-
-
Adams, D.J.1
Dai, M.2
Pellegrino, G.3
Wagner, B.K.4
Stern, A.M.5
Shamji, A.F.6
Schreiber, S.L.7
-
18
-
-
84864448811
-
Proteasome deubiquitinases as novel targets for cancer therapy
-
D'Arcy P., Linder S. Proteasome deubiquitinases as novel targets for cancer therapy. Int. J. Biochem. Cell Biol. 2012, 44:1729-1738.
-
(2012)
Int. J. Biochem. Cell Biol.
, vol.44
, pp. 1729-1738
-
-
D'Arcy, P.1
Linder, S.2
-
19
-
-
70449723717
-
Ubiquilin and p97/VCP bind erasin, forming a complex involved in ERAD
-
Lim P.J., Danner R., Liang J., Doong H., Harman C., Srinivasan D., Rothenberg C., Wang H., Ye Y., Fang S., Monteiro M.J. Ubiquilin and p97/VCP bind erasin, forming a complex involved in ERAD. J. Cell Biol. 2009, 187:201-217.
-
(2009)
J. Cell Biol.
, vol.187
, pp. 201-217
-
-
Lim, P.J.1
Danner, R.2
Liang, J.3
Doong, H.4
Harman, C.5
Srinivasan, D.6
Rothenberg, C.7
Wang, H.8
Ye, Y.9
Fang, S.10
Monteiro, M.J.11
-
20
-
-
79960637590
-
Protein targeting and degradation are coupled for elimination of mislocalized proteins
-
Hessa T., Sharma A., Mariappan M., Eshleman H.D., Gutierrez E., Hegde R.S. Protein targeting and degradation are coupled for elimination of mislocalized proteins. Nature 2011, 475:394-397.
-
(2011)
Nature
, vol.475
, pp. 394-397
-
-
Hessa, T.1
Sharma, A.2
Mariappan, M.3
Eshleman, H.D.4
Gutierrez, E.5
Hegde, R.S.6
-
21
-
-
64549108112
-
Oxidative stress by targeted agents promotes cytotoxicity in hematologic malignancies
-
Chandra J. Oxidative stress by targeted agents promotes cytotoxicity in hematologic malignancies. Antioxid. Redox Signaling 2009, 11:1123-1137.
-
(2009)
Antioxid. Redox Signaling
, vol.11
, pp. 1123-1137
-
-
Chandra, J.1
-
22
-
-
0345707597
-
An endogenous electrophile that modulates the regulatory mechanism of protein turnover: inhibitory effects of 15-deoxy-Delta 12,14-prostaglandin J2 on proteasome
-
Shibata T., Yamada T., Kondo M., Tanahashi N., Tanaka K., Nakamura H., Masutani H., Yodoi J., Uchida K. An endogenous electrophile that modulates the regulatory mechanism of protein turnover: inhibitory effects of 15-deoxy-Delta 12,14-prostaglandin J2 on proteasome. Biochemistry 2003, 42:13960-13968.
-
(2003)
Biochemistry
, vol.42
, pp. 13960-13968
-
-
Shibata, T.1
Yamada, T.2
Kondo, M.3
Tanahashi, N.4
Tanaka, K.5
Nakamura, H.6
Masutani, H.7
Yodoi, J.8
Uchida, K.9
-
23
-
-
27144441722
-
Oxidative modification of proteasome: identification of an oxidation-sensitive subunit in 26 S proteasome
-
Ishii T., Sakurai T., Usami H., Uchida K. Oxidative modification of proteasome: identification of an oxidation-sensitive subunit in 26 S proteasome. Biochemistry 2005, 44:13893-13901.
-
(2005)
Biochemistry
, vol.44
, pp. 13893-13901
-
-
Ishii, T.1
Sakurai, T.2
Usami, H.3
Uchida, K.4
-
24
-
-
0022967083
-
Redox cycling of anthracyclines by cardiac mitochondria. I. Anthracycline radical formation by NADH dehydrogenase
-
Davies K.J., Doroshow J.H. Redox cycling of anthracyclines by cardiac mitochondria. I. Anthracycline radical formation by NADH dehydrogenase. J. Biol. Chem. 1986, 261:3060-3067.
-
(1986)
J. Biol. Chem.
, vol.261
, pp. 3060-3067
-
-
Davies, K.J.1
Doroshow, J.H.2
-
25
-
-
81855183258
-
Novel activity of acriflavine against colorectal cancer tumor cells
-
Hassan S., Laryea D., Mahteme H., Felth J., Fryknas M., Fayad W., Linder S., Rickardson L., Gullbo J., Graf W., Pahlman L., Glimelius B., Larsson R., Nygren P. Novel activity of acriflavine against colorectal cancer tumor cells. Cancer Sci. 2011, 102:2206-2213.
-
(2011)
Cancer Sci.
, vol.102
, pp. 2206-2213
-
-
Hassan, S.1
Laryea, D.2
Mahteme, H.3
Felth, J.4
Fryknas, M.5
Fayad, W.6
Linder, S.7
Rickardson, L.8
Gullbo, J.9
Graf, W.10
Pahlman, L.11
Glimelius, B.12
Larsson, R.13
Nygren, P.14
-
26
-
-
0037075063
-
Mining the National Cancer Institute's tumor-screening database: identification of compounds with similar cellular activities
-
Rabow A.A., Shoemaker R.H., Sausville E.A., Covell D.G. Mining the National Cancer Institute's tumor-screening database: identification of compounds with similar cellular activities. J. Med. Chem. 2002, 45:818-840.
-
(2002)
J. Med. Chem.
, vol.45
, pp. 818-840
-
-
Rabow, A.A.1
Shoemaker, R.H.2
Sausville, E.A.3
Covell, D.G.4
-
27
-
-
17844396225
-
Linking tumor cell cytotoxicity to mechanism of drug action: an integrated analysis of gene expression, small-molecule screening and structural databases
-
Covell D.G., Wallqvist A., Huang R., Thanki N., Rabow A.A., Lu X.J. Linking tumor cell cytotoxicity to mechanism of drug action: an integrated analysis of gene expression, small-molecule screening and structural databases. Proteins 2005, 59:403-433.
-
(2005)
Proteins
, vol.59
, pp. 403-433
-
-
Covell, D.G.1
Wallqvist, A.2
Huang, R.3
Thanki, N.4
Rabow, A.A.5
Lu, X.J.6
|